A Pharmacokinetic and Safety Study of IV Gallium Nitrate (Ganite) in Cystic Fibrosis Patients
Completed
Cystic Fibrosis Foundation
Phase 1
2010-04-01
The purpose of this research study is to test the pharmacokinetics, safety, and tolerability
of an intravenous infusion of a drug called Ganite (gallium nitrate) in patients with cystic
fibrosis. We want to see this drug is safe and tolerable and to see if high levels of the
drug are found in the sputum.
Funding Source - Food and Drug Administration (FDA) Office of Orphan Products Development
(OOPD)
A Pharmacokinetic and Safety Study of IV Gallium Nitrate (Ganite) in Cystic Fibrosis Patients
Completed
Cystic Fibrosis Foundation Therapeutics
Phase 1
2010-04-01
The purpose of this research study is to test the pharmacokinetics, safety, and tolerability
of an intravenous infusion of a drug called Ganite (gallium nitrate) in patients with cystic
fibrosis. We want to see this drug is safe and tolerable and to see if high levels of the
drug are found in the sputum.
Funding Source - Food and Drug Administration (FDA) Office of Orphan Products Development
(OOPD)
A Pharmacokinetic and Safety Study of IV Gallium Nitrate (Ganite) in Cystic Fibrosis Patients
Completed
University of Washington
Phase 1
2010-04-01
The purpose of this research study is to test the pharmacokinetics, safety, and tolerability
of an intravenous infusion of a drug called Ganite (gallium nitrate) in patients with cystic
fibrosis. We want to see this drug is safe and tolerable and to see if high levels of the
drug are found in the sputum.
Funding Source - Food and Drug Administration (FDA) Office of Orphan Products Development
(OOPD)
IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)
Recruiting
Cystic Fibrosis Foundation
Phase 1
2021-06-17
The purpose of this study is to assess the safety and tolerability of two 5-day infusion
cycles of IV gallium in adult patients with CF who are infected with NTM.
Funding Source - FDA OOPD
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.